European Biotech Patent Case Law Webinar
European Patent Attorneys Simon O'Brien and Tom Pagdin present our latest webinar update of new and important EPO biotechnology patent case law.
The webinar will include discussion of the latest European biotech patent case law developments.
Simon O'Brien was appointed partner in 2010 and is a Chartered and European Patent Attorney. His area of expertise encompasses both biological and chemical subject matter including the fields of molecular biology, biotechnology, biochemistry, food technology and nutrition, diagnostics, pharmaceuticals, and polymer chemistry. Simon advises on all aspects of patent law, including patent drafting and prosecution, opposition and appeal proceedings.
Simon has lectured at numerous conferences on life science issues in the patent arena, particularly in the fields of personalised medicine. IAM Patent 1000 writes that Simon's "contentious experience means that he can turn a weak biochemical patent into an unimpeachable one before the examiners."
Senior Associate Tom Pagdin joined D Young & Co in 2012. Tom's background is primarily in immunology and molecular genetics with a PhD in molecular genetics. He is particularly experienced in sectors relating to antibodies, chimeric antigen receptors, RNAi technologies, vaccines, viral vectors, gene editing technologies, diagnostics, peptides, food technology and nutritional compositions. Tom represents a wide range of clients, from academic institutions and spin-outs to multinational companies and his work covers all areas of patent law.
The webinar will run at 9am, noon and 5pm GMT (UK time) on Tuesday 08 February 2022. To register for your preferred webinar time (and select local time options), please select the appropriate link below:
- Register for the 9am (GMT) webinar
- Register for the 12pm (GMT) webinar
- Register for the 5pm (GMT) webinar
Once your registration has been approved, please be sure to check system requirements to avoid any connection issues.
Sign up for webinar invitations